Immediate Impact
81 standout
Citing Papers
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Works of J.F. Blanc being referenced
O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J.F. Blanc | 32 | 74 | 21 | 41 | 13 | 98 | |
| Peter R. Galle | 21 | 58 | 22 | 42 | 15 | 102 | |
| Keisuke Koroki | 18 | 53 | 14 | 25 | 15 | 79 | |
| Jigjidsuren Chinburen | 15 | 49 | 24 | 41 | 9 | 102 | |
| Jayoun Lee | 24 | 62 | 12 | 70 | 15 | 165 | |
| Liqun Wu | 30 | 73 | 22 | 29 | 12 | 110 | |
| Tobias Meischl | 50 | 49 | 27 | 38 | 16 | 109 | |
| Adelina Horhat | 33 | 80 | 15 | 73 | 12 | 140 | |
| Yehia I. Abugabal | 24 | 46 | 12 | 26 | 11 | 79 | |
| Yi Ding | 46 | 35 | 16 | 24 | 9 | 116 | |
| Iqtedar A Muazzam | 21 | 86 | 23 | 72 | 11 | 117 |
All Works
Loading papers...